Nat West Group PLC Gilead Sciences, Inc. Transaction History

Nat West Group PLC

$338 Million
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 24, 2023	SELL	$77.31 - $88.08 $60,842 - $69,318	-787 Reduced 17.7%	3,660 $303,000
Q4 2022 Jan 27, 2023	SELL	$62.32 - $89.47 $84,692 - $121,589	-1,359 Reduced 23.41%	4,447 $0
Q2 2022 Jul 20, 2022	SELL	$57.72 - $65.01 $202,020 - $227,535	-3,500 Reduced 37.61%	5,806 $359,000
Q3 2021 Oct 26, 2021	SELL	$67.69 - $73.03 $1.66 Million - $1.79 Million	-24,497 Reduced 72.47%	9,306 $650,000
Q2 2021 Jul 21, 2021	BUY	$63.47 - $69.35 $17,771 - $19,418	280 Added 0.84%	33,803 $2.33 Million
Q1 2021 Apr 16, 2021	BUY	$60.0 - $68.46 $8,040 - $9,173	134 Added 0.4%	33,523 $2.17 Million
Q4 2020 Feb 04, 2021	SELL	$56.65 - $64.55 $510,076 - $581,208	-9,004 Reduced 21.24%	33,389 $1.95 Million
Q3 2020 Nov 10, 2020	BUY	$62.1 - $78.08 $339,749 - $427,175	5,471 Added 14.82%	42,393 $2.68 Million
Q2 2020 Jul 16, 2020	BUY	$72.34 - $84.0 $290,879 - $337,764	4,021 Added 12.22%	36,922 $2.84 Million
Q1 2020 May 07, 2020	BUY	$62.63 - $80.22 $264,048 - $338,207	4,216 Added 14.7%	32,901 $2.46 Million
Q4 2019 Feb 06, 2020	BUY	$61.62 - $67.78 $623,163 - $685,459	10,113 Added 54.45%	28,685 $1.86 Million
Q3 2019 Oct 24, 2019	SELL	$62.51 - $69.0 $4,938 - $5,451	-79 Reduced 0.42%	18,572 $1.18 Million
Q2 2019 Jul 25, 2019	BUY	$61.87 - $69.38 $302,853 - $339,615	4,895 Added 35.58%	18,651 $1.26 Million
Q1 2019 May 08, 2019	BUY	$62.53 - $70.05 $73,160 - $81,958	1,170 Added 9.3%	13,756 $895,000
Q4 2018 Feb 12, 2019	BUY	$60.54 - $79.0 $13,379 - $17,459	221 Added 1.79%	12,586 $787,000
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $19.3 Million - $21.4 Million	-271,087 Reduced 95.64%	12,365 $954,000
Q2 2018 Aug 13, 2018	BUY	$64.88 - $75.68 $457,858 - $534,073	7,057 Added 2.55%	283,452 $20.1 Million
Q1 2018 May 14, 2018	BUY	$72.84 - $88.8 $581,117 - $708,446	7,978 Added 2.97%	276,395 $20.8 Million
Q4 2017 Feb 06, 2018	BUY	$71.15 - $83.52 $363,434 - $426,620	5,108 Added 1.94%	268,417 $19.2 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $1.86 Million - $2.21 Million	25,822 Added 10.87%	263,309 $21.3 Million
Q2 2017 Aug 14, 2017	BUY	N/A	237,487	237,487 $16.8 Million

Others Institutions Holding GILD

# of Institutions

1,931

Shares Held

991M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$10.8 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.4 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$6.88 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.55 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.41 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nat West Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Nat West Group PLC with notifications on news.

Account